Metabolic changes during 5 months treatment with olanzapine or risperidone: Preliminary results from randomized trial

被引：0
|
作者：
Smith, RC
Lindenmayer, JP
Buga, A
Matute, M
Vaidhyanathaswamy, S
Warner-Cohen, J
机构：
[1] NYU, Sch Med, Hewlett, NY USA
[2] Manhattan Psychiat Ctr, Wards Isl, NY USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2004年 / 29卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：S226 / S226
页数：1
相关论文
共 50 条
  • [41] Treatment of delirium with risperidone: Results from an open-label prospective trial
    Mittal, D
    Jimerson, N
    Peoples, E
    Johnson, W
    Kennedy, R
    Torres, R
    Nasrallah, H
    PSYCHOSOMATICS, 2003, 44 (02) : 139 - 140
  • [42] Marked increase in adiposity during olanzapine vs risperidone treatment: Results of a placebo-controlled study in normal dogs
    Ader, M
    Kim, SP
    Catalano, KJ
    Ionut, V
    Hucking, K
    Richey, JM
    Kabir, M
    Bergman, RN
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S320 - S321
  • [43] RESULTS OF A RANDOMIZED TRIAL OF TREATING ABNORMAL HYPERMETROPIA FROM THE AGE OF 6 MONTHS
    INGRAM, RM
    ARNOLD, PE
    DALLY, S
    LUCAS, J
    BRITISH JOURNAL OF OPHTHALMOLOGY, 1990, 74 (03) : 158 - 159
  • [44] Comparison of metabolic changes in patients with schizophrenia during randomized treatment with intramuscular olanzapine long-acting injection versus oral olanzapine (vol 26, pg 422, 2011)
    McDonnell, D. P.
    Kryzhanovskaya, L. A.
    Zhao, F.
    Detke, H. C.
    Feldman, P. D.
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2011, 26 (07) : 536 - 536
  • [45] Prevalence of metabolic syndrome in patients with schizophrenia, and metabolic changes after 3 months of treatment with antipsychotics - results from a German observational study
    Kraemer, Susanne
    Minarzyk, Anette
    Forst, Thomas
    Kopf, Daniel
    Hundemer, Hans-Peter
    BMC PSYCHIATRY, 2011, 11
  • [46] THE ROLE OF DOXORUBICIN IN THE TREATMENT OF RHABDOMYOSARCOMA: PRELIMINARY RESULTS FROM THE EPSSG RMS2005 RANDOMIZED TRIAL
    Bisogno, G.
    De Salvo, G. L.
    Bergeron, C.
    Carli, M.
    Ferrari, A.
    Jenney, M.
    Mercks, H.
    Kelsey, A.
    Gallego, S.
    Chisholm, J.
    Orbach, D.
    Martelli, H.
    Oberlin, O.
    Stevens, M.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S133 - S134
  • [47] A RANDOMIZED CLINICAL-TRIAL OF TREATMENT FOR ATYPICAL DEPRESSION - PRELIMINARY-RESULTS
    SCHAFFER, MH
    CHENG, QC
    MCINTIRE, D
    EAVES, G
    KOBES, R
    SILVER, P
    JARRETT, RB
    BIOLOGICAL PSYCHIATRY, 1994, 35 (09) : 617 - 618
  • [48] Prevalence of metabolic syndrome in patients with schizophrenia, and metabolic changes after 3 months of treatment with antipsychotics - results from a German observational study
    Susanne Kraemer
    Anette Minarzyk
    Thomas Forst
    Daniel Kopf
    Hans-Peter Hundemer
    BMC Psychiatry, 11
  • [49] Differential effects of quetiapine, olanzapine and risperidone on glucose metabolism in patients with schizophrenia: Results from a 24-week, randomized study
    Ratner, Robert E.
    Newcomer, John W.
    Eriksson, Jan W.
    Emsley, Robin
    Meulien, Didier
    Miller, Frank
    Risberg, Sofia
    Leonova-Edlund, Julia
    Leong, Ronald
    Zukin, Stephen R.
    Brecher, Martin
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S185 - S185
  • [50] Examination of cognitive function during six months of calorie restriction: Results of a randomized controlled trial
    Martin, Corby K.
    Anton, Stephen D.
    Han, Hongmei
    York-Crowe, Emily
    Redman, Leanne M.
    Ravussin, Eric
    Williamson, Donald A.
    REJUVENATION RESEARCH, 2007, 10 (02) : 179 - 189
12345